Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
AI channel feed
Amgen teams up with Amazon on AI platform to enhance new Ohio manufacturing site
Last year
Manufacturing
European AI startup raises $24M for protein design software service
Last year
Financing
Shionogi brings generative AI to medical conferences with 'Warrior' portrait campaign
Last year
Pharma
Marketing
Khosla Ventures leads $38M seed round for organoid startup Vivodyne
Last year
Financing
Nvidia signs deal with Genentech to pair drugmaker's machine learning with chip supplier's tech
Last year
Deals
Klick Health agency adds AI teams to accelerate pharma and healthcare marketing projects
Last year
Pharma
Marketing
Amgen lines up new AI biotech partner in PostEra to develop small molecule medicines
Last year
Deals
Generate:Biomedicines opens the hood on its AI software for making proteins
Last year
R&D
Backed by ex-Google CEO Eric Schmidt, a new nonprofit looks to 'solve science' with AI
Last year
Generative AI biotech partners with cancer center in bid to speed up CAR-T development in solid tumors
Last year
Deals
Cell/Gene Tx
Biden signs sweeping executive order on AI, with changes coming for FDA and healthcare
Last year
FDA+
After years of hype, the first AI-designed drugs fall short in the clinic
Last year
In Focus
FDA launches new digital health adcomm to tackle incoming complexities
Last year
FDA+
Health Tech
Sanofi adds another AI alliance, this time for biologics with Baidu CEO’s startup
Last year
Deals
China
AI-driven biotech Iambic snags $100M to enter the clinic next year in HER2 field
Last year
Financing
Startups
Exscientia ends cancer study as it focuses on other trials of AI-driven drug candidates
Last year
R&D
Pharma
Exclusive: 'Faster isn't better' — Atomwise moves from partnerships to pipeline with TYK2 drug
Last year
R&D
FDA+ roundup: Agency reopens AI discussion paper for comments amid two-day workshop
Last year
Pharma
FDA+
Nobel Prize winner Demis Hassabis talks about his vision for Isomorphic and AI’s future in biotech
Last year
People
BenevolentAI, Exscientia on the comeback trail after securing separate AI drug discovery deals with Merck KGaA
Last year
Deals
AlphaFold, meet AlphaMissense: Google DeepMind's AI successor predicts how 71M mutations cause disease
Last year
Abcam founder Jonathan Milner opposes Danaher buyout; First Wave tries to find new life in Sanofi drug
Last year
News Briefing
Flagship’s AI unicorn Generate raises $273M Series C, as first drug in 17-program pipeline enters the clinic
Last year
Financing
Andreessen Horowitz-backed startup lands $200M for AI-based drug discovery
Last year
Financing
R&D
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit